All stock lists
Castle Biosciences Inc (NASDAQ:CSTL)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
33.08-0.11 (-0.33%)
Insider Score
––Not scored
CSTL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CSTL analyst forecast
CSTL analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CSTL 12-month price target
No published price targets in the last 12 months.
Best analysts covering CSTL
- Canaccord Genuity60%success rate · 5 calls
- Lake Street60%success rate · 5 calls
- Baird55%success rate · 11 calls
- BTIG50%success rate · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CSTL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | BTIG | Buy | — | — | Reiterated | 2026-08-03 |
| — | BTIG | Buy | — | — | Reiterated | 2026-05-13 |
| — | Baird | Outperform | — | — | Reiterated | 2026-05-07 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-04-20 |
| — | Baird | Outperform | — | — | Reiterated | 2026-02-27 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-01-26 |
| — | Lake Street | Buy | — | — | Reiterated | 2026-01-12 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-01-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-12-22 |
| — | BTIG | Buy | — | — | Reiterated | 2025-12-12 |
| — | BTIG | Buy | — | — | Reiterated | 2025-11-05 |
| — | Baird | Outperform | — | — | Reiterated | 2025-11-04 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-09-09 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-05-21 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-05-06 |
| — | Lake Street | Buy | — | — | Reiterated | 2025-05-06 |
| — | Baird | Outperform | — | — | Reiterated | 2025-02-28 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-01-02 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-11-06 |
| — | Baird | Outperform | — | — | Reiterated | 2024-11-05 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-11-05 |
| — | Lake Street | Buy | — | — | Reiterated | 2024-11-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-10-29 |
| — | BTIG | Buy | — | — | Reiterated | 2024-10-14 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-08-06 |
| — | Baird | Outperform | — | — | Reiterated | 2024-08-06 |
| — | Baird | Outperform | — | — | Reiterated | 2024-07-05 |
| — | Baird | Outperform | — | — | Reiterated | 2024-05-03 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-03-01 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-03-01 |
| — | Keybanc | Overweight | — | — | Reiterated | 2023-08-04 |
| — | Lake Street | Buy | — | — | Reiterated | 2023-07-07 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-07-06 |
| — | BTIG | Buy | — | — | Reiterated | 2023-06-15 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2023-06-07 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-06-06 |
| — | Lake Street | Buy | — | — | Reiterated | 2023-06-05 |
| — | Baird | Outperform | — | — | Reiterated | 2023-06-05 |
| — | SVB Securities | Outperform | — | — | Reiterated | 2023-06-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-05-08 |
| — | Keybanc | Overweight | — | — | Reiterated | 2023-05-05 |
| — | Baird | Outperform | — | — | Reiterated | 2023-05-04 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-05-04 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-03-02 |
| — | Baird | Outperform | — | — | Reiterated | 2023-03-01 |
| — | Scotiabank | Outperform | — | — | Reiterated | 2023-01-05 |
| — | Baird | Outperform | — | — | Reiterated | 2022-11-03 |
| — | SVB Leerink | Market Outperform | — | — | Reiterated | 2022-08-09 |
| — | Baird | Outperform | — | — | Reiterated | 2022-08-09 |
| — | Keybanc | Overweight | — | — | Reiterated | 2022-05-11 |
| — | Baird | Outperform | — | — | Reiterated | 2022-05-10 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-05-10 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2022-04-05 |
| — | Lake Street | Buy | — | — | Reiterated | 2022-03-01 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2022-01-07 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-11-09 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-07-14 |
| — | Lake Street | Buy | — | — | Reiterated | 2021-04-30 |
| — | Keybanc | Overweight | — | — | Reiterated | 2021-02-03 |
| — | KeyBanc | Overweight | — | — | Reiterated | 2021-02-03 |
CSTL earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | -0.23 | -0.08 | $79.9M | $87.0M |
| 2026-05-06 | -0.49 | -0.49 | $79.2M | $84.2M |
| 2026-07-30 | -0.41 | -0.07 | $86.2M | $103.5M |
| 2026-11-05 | -0.35 | 0.00 | $92.4M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.